Cargando…

What is the impact of microvascular complications of diabetes on severe COVID-19?

Evidence suggests severe coronavirus disease-19 (COVID-19) infection is characterised by pulmonary and systemic microvasculature dysfunction, specifically, acute endothelial injury, hypercoagulation and increased capillary permeability. Diabetes, which is also characterised by vascular injury in its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basra, Ruman, Whyte, Martin, Karalliedde, Janaka, Vas, Prashanth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719364/ https://www.ncbi.nlm.nih.gov/pubmed/34979154 http://dx.doi.org/10.1016/j.mvr.2021.104310

Ejemplares similares

Microvascular disease in diabetes and severe COVID-19 outcomes
por: Corcillo, Antonella, et al.
Publicado: (2021)

The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19
por: Whyte, Martin B., et al.
Publicado: (2020)

Diabetes, obesity and COVID‐19: A complex interplay
por: Vas, Prashanth, et al.
Publicado: (2020)

People With Type 1 Diabetes of African Caribbean Ethnicity Are at Increased Risk of Developing Sight-Threatening Diabetic Retinopathy
por: Mangelis, Anastasios, et al.
Publicado: (2023)

Endothelial Factors and Diabetic Nephropathy
por: Karalliedde, Janaka, et al.
Publicado: (2011)

Could Exogenous Insulin Ameliorate the Metabolic Dysfunction Induced by Glucocorticoids and COVID-19?
por: Whyte, Martin Brunel, et al.
Publicado: (2021)

COVID-19 induced type 1 diabetes: A systematic review of case reports and series
por: Stathi, Dimitra, et al.
Publicado: (2023)

Diabetic retinopathy is independently associated with increased risk of intubation: A single centre cohort study of patients with diabetes hospitalised with COVID-19
por: Corcillo, Antonella, et al.
Publicado: (2021)

COVID-19 and the hidden threat of diabetic microvascular complications
por: Zaghloul, Hadeel, et al.
Publicado: (2022)

Presentation of new onset type 1 diabetes with diabetic ketoacidosis and hyperosmolar hyperglycaemia after a single dose of nivolumab and ipilimumab
por: Stathi, Dimitra, et al.
Publicado: (2023)

Diabetic Microvascular Complications
por: Migdalis, I., et al.
Publicado: (2018)

Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness
por: Kum, Francesca, et al.
Publicado: (2010)

The Putative Role of the Antiageing Protein Klotho in Cardiovascular and Renal Disease
por: Maltese, Giuseppe, et al.
Publicado: (2012)

Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agents
por: Gnudi, Luigi, et al.
Publicado: (2016)

Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies
por: Harris, Stewart B., et al.
Publicado: (2022)

Diabetes technology including automated insulin delivery systems to manage hyperglycemia in a failing pancreatic graft: Case series of people with type 1 diabetes and a pancreas kidney or pancreas‐only transplant
por: Stathi, Dimitra, et al.
Publicado: (2023)

Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria
por: Maltese, Giuseppe, et al.
Publicado: (2017)

Low levels of circulating anti-ageing hormone Klotho predict the onset and progression of diabetic retinopathy
por: Corcillo, Antonella, et al.
Publicado: (2020)

Microvascular disease in diabetes and severe COVID-19 outcomes – Authors' reply
por: Colhoun, Helen M, et al.
Publicado: (2021)

The Role of Biofactors in Diabetic Microvascular Complications
por: Ziegler, Dan, et al.
Publicado: (2022)

Inflammation and diabetic retinal microvascular complications
por: Zhang, Wenbo, et al.
Publicado: (2011)

Inflammation in the pathogenesis of microvascular complications in diabetes
por: Nguyen, Dung V., et al.
Publicado: (2012)

MicroRNA and Microvascular Complications of Diabetes
por: Barutta, F., et al.
Publicado: (2018)

Genetics of diabetes-associated microvascular complications
por: Lyssenko, Valeriya, et al.
Publicado: (2023)

Impact of White-Coat Hypertension on Microvascular Complications in Type 2 Diabetes
por: Kramer, Caroline K., et al.
Publicado: (2008)

The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications
por: Zhang, Ziwei, et al.
Publicado: (2023)

Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years
por: Fountoulakis, Nikolaos, et al.
Publicado: (2017)

Analysis of microvascular and neurodegenerative complications of mild COVID-19
por: Kolkedi, Zsofia, et al.
Publicado: (2022)

Reducing the incidence of predictors of cardio-metabolic disease and dysglycaemia with lifestyle modification in at-risk persons – results of further analyses of DIABRISK-SL in those below 18 years of age
por: Fountoulakis, Nikolaos, et al.
Publicado: (2019)

Reduced Levels of the Antiaging Hormone Klotho are Associated With Increased Aortic Stiffness in Diabetic Kidney Disease
por: Fountoulakis, Nikolaos, et al.
Publicado: (2023)

The Ubiquitin-Proteasome System and Microvascular Complications of Diabetes
por: Yadranji Aghdam, Saeed, et al.
Publicado: (2013)

Is cognitive impairment the fourth diabetic microvascular complication?
por: Kawamura, Takahiko, et al.
Publicado: (2011)

Vaccinium as Potential Therapy for Diabetes and Microvascular Complications
por: Huang, Hui, et al.
Publicado: (2023)

Retinal microvascular morphology versus COVID-19: What to anticipate?
por: Erogul, Ozgur, et al.
Publicado: (2022)

Painless foot drop: an unusual acute presentation of new onset type 1 diabetes mellitus
por: Corcillo, Antonella, et al.
Publicado: (2021)

Diabetes and severity of COVID-19: What is the link?
por: Pitocco, D., et al.
Publicado: (2020)

DIABRISK - SL Prevention of cardio-metabolic disease with life style modification in young urban Sri Lankan's - study protocol for a randomized controlled trial
por: Wijesuriya, Mahen, et al.
Publicado: (2011)

Severity and multiplicity of microvascular complications are associated with QT interval prolongation in patients with type 2 diabetes
por: Kobayashi, Shunsuke, et al.
Publicado: (2017)

In vivo demonstration of microvascular thrombosis in severe COVID-19
por: do Espírito Santo, Douglas Alexandre, et al.
Publicado: (2020)

What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications?
por: Bonnefond, Amélie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uqm8f1k4qic84r61oboo83h24k